Tango Therapeutics (TNGX) FCF Margin (QoQ) (2020 - 2025)

Tango Therapeutics (TNGX) FCF Margin (QoQ) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Tango Therapeutics 4.32 Bn 3.30 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 109,869.00
Jun 30, 2025 -38,179.00
Mar 31, 2025 13,502.00
Dec 31, 2024 -62,634.00
Sep 30, 2024 -16,140.00
Jun 30, 2024 46,294.00
Mar 31, 2024 -10,198.00
Dec 31, 2023 -19,225.00
Sep 30, 2023 -11,807.00
Jun 30, 2023 44,395.00
Mar 31, 2023 -15,901.00
Dec 31, 2022 -7,751.00
Sep 30, 2022 15,806.00
Jun 30, 2022 -1,381.00
Mar 31, 2022 -23,278.00
Dec 31, 2021 3,193.00
Sep 30, 2021 -28,260.00
Jun 30, 2021 17,532.00
Mar 31, 2021 -19,263.00
Dec 31, 2020 -2,233.00